<DOC>
	<DOCNO>NCT02981407</DOCNO>
	<brief_summary>The purpose study compare two red blood cell transfusion strategy ( liberal restrictive ) patient acute myocardial infarction anemic .</brief_summary>
	<brief_title>Myocardial Ischemia Transfusion</brief_title>
	<detailed_description>In clinical setting , evidence suggest safe wait give blood transfusion . However , suffer heart attack , lack high quality evidence guide transfusion . This 3500 subject multi-center randomize trial fill void . Hospital inpatient diagnose myocardial infarction blood count less 10 g/dL randomize receive either liberal restrictive transfusion strategy . Patients randomized liberal transfusion strategy receive red blood cell transfusion anytime blood count le 10 g/dL . Patients randomize restrictive transfusion strategy permit receive blood transfusion blood count 8 g/dL physician believe patient 's best interest . A transfusion strongly recommend blood count drop less 7 g/dL . If patient symptom angina ( e.g. , chest discomfort describe pressure heaviness ) go away medication , blood transfusion order regardless blood count . The transfusion strategy maintain hospital discharge maximum 30 day . Patients follow 30 day clinically relevant outcome . Vital status confirm 180 day .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<criteria>18 year age old Either ST segment elevation myocardial infarction Non ST segment elevation myocardial infarction consistent 3rd Universal Definition Myocardial Infarction criterion occur admission index hospitalization Hemoglobin concentration le 10 g/dL time random allocation Uncontrolled acute bleeding time randomization define need uncrossed nontype specific blood Decline blood transfusion Scheduled cardiac surgery current admission Receiving palliative treatment Known followup possible 30 day Previously participate MINT Currently enrol compete study interferes intervention followup MINT enrol compete study approve local Institutional Review Board .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Red Blood Cell Transfusion</keyword>
	<keyword>Anemia</keyword>
	<keyword>Heart Disease</keyword>
	<keyword>Cardiovascular Disease</keyword>
</DOC>